Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registry

被引:18
|
作者
Faehndrich, Sebastian [1 ]
Herr, Christian [1 ]
Greulich, Timm [2 ]
Seibert, Martina [1 ]
Lepper, Philipp M. [1 ]
Bernhard, Nikolas [1 ]
Luetzow, Cindy [1 ]
Vogelmeier, Claus [2 ]
Bals, Robert [1 ]
机构
[1] Saarland Univ Hosp, Dept Internal Med Pulmonol 5, Allergol, Intens Care Med, Homburg, Germany
[2] Univ Marburg, Dept Pulmonol Marburg, Marburg, Germany
关键词
OBSTRUCTIVE PULMONARY-DISEASE; ALPHA(1)-ANTITRYPSIN DEFICIENCY; ANTITRYPSIN DEFICIENCY; GENDER-DIFFERENCES; COPD; INDIVIDUALS; LIFE;
D O I
10.3109/15412555.2015.1023785
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Alpha-1-antitrypsin deficiency (AATD) is a rare condition with clinical manifestations of the lung and the liver. There is evidence that the gender affects the clinical presentation of non-AATD chronic obstructive lung disease (COPD). The aim of this study was to analyze gender-dependent disease pattern in AATD-based COPD. Data from 1066 individuals from the German AATD registry were analyzed by descriptive and analytical statistics. The AAT genotypes comprised 820 individuals with PiZZ (male 56%, female 45%), 109 with PI SZ (male 55%; female 45%), and others (n = 137). A subgroup of 422 patients with available post-bronchodilator FEV1% predicted was analyzed in detail after stratification in spirometric GOLD stages I-IV. The age of the registered individuals is 52.2 +/- 13.4 years (male: 51.91 +/- 13.86 years; female: 52.76 +/- 13.39 years). Female patients with GOLD I-IV showed lower numbers of pack-years and lower BMI. The time between the first symptom and the establishment of the correct diagnosis was significantly longer in female (14.47 +/- 16.46 years) as compared to male individuals (12.39 +/- -14.38 years, p = 0.04). In conclusion, the data of the registry allow to characterize the natural course of the disease and highlight differences in the clinical presentation of patients with AATD-dependent COPD.
引用
收藏
页码:58 / 62
页数:5
相关论文
共 50 条
  • [21] Lung clearance index for monitoring early lung disease in alpha-1-antitrypsin deficiency
    Fuchs, Susanne I.
    Schwerk, Nicolaus
    Pittschieler, Klaus
    Ahrens, Frank
    Baden, Winfried
    Bals, Robert
    Faehndrich, Sebastian
    Gleiber, Wolfgang
    Griese, Matthias
    Huelskamp, Georg
    Koehnlein, Thomas
    Reckling, Ludmilla
    Rietschel, Ernst
    Staab, Doris
    Gappa, Monika
    RESPIRATORY MEDICINE, 2016, 116 : 93 - 99
  • [22] Alpha-1-antitrypsin deficiency
    Perlmutter, DH
    SEMINARS IN LIVER DISEASE, 1998, 18 (03) : 217 - 225
  • [23] ALPHA-1-ANTITRYPSIN DEFICIENCY
    BRESLIN, ABX
    PAPUA NEW GUINEA MEDICAL JOURNAL, 1982, 25 (04) : 209 - 211
  • [24] ALPHA-1-ANTITRYPSIN DEFICIENCY
    MANSFELD, J
    PRAXIS UND KLINIK DER PNEUMOLOGIE, 1977, 31 (05): : 556 - 557
  • [25] ALPHA-1-ANTITRYPSIN DEFICIENCY
    KUNZER, W
    KLINISCHE PADIATRIE, 1977, 189 (03): : 199 - 205
  • [26] ALPHA-1-ANTITRYPSIN DEFICIENCY
    IDELL, S
    COHEN, AB
    CLINICS IN CHEST MEDICINE, 1983, 4 (03) : 359 - 375
  • [27] Alpha-1-antitrypsin deficiency
    Bouchecareilh, Marion
    M S-MEDECINE SCIENCES, 2014, 30 (10): : 889 - 895
  • [28] ALPHA-1-ANTITRYPSIN DEFICIENCY
    CATZ, EG
    SPEIR, WA
    SOUTHERN MEDICAL JOURNAL, 1984, 77 (04) : 479 - 483
  • [29] The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
    Tobias Meischl
    Karin Schmid-Scherzer
    Florian Vafai-Tabrizi
    Gert Wurzinger
    Eva Traunmüller-Wurm
    Kristina Kutics
    Markus Rauter
    Fikreta Grabcanovic-Musija
    Simona Müller
    Norbert Kaufmann
    Judith Löffler-Ragg
    Arschang Valipour
    Georg-Christian Funk
    Respiratory Research, 24
  • [30] ALPHA-1-ANTITRYPSIN DEFICIENCY
    CARRELL, RW
    BELL, OF
    NEW ZEALAND MEDICAL JOURNAL, 1973, 78 (497) : 174 - 174